XML Financial’s AstraZeneca AZN Stock Holding History

XML Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464K	Sell	2,449 -150	-6%	-$28.2K	0.03%	298
2026 Q1	$513K	Hold	2,599	–	–	0.04%	261
2025 Q4	$478K	Sell	2,599 -475	-15%	-$83.3K	0.04%	264
2025 Q3	$472K	Hold	3,074	–	–	0.04%	257
2025 Q2	$430K	Hold	3,074	–	–	0.04%	256
2025 Q1	$452K	Sell	3,074 -125	-4%	-$18.1K	0.04%	236
2024 Q4	$419K	Buy	3,199 +325	+11%	+$45.5K	0.04%	252
2024 Q3	$448K	Hold	2,874	–	–	0.04%	243
2024 Q2	$448K	Sell	2,874 -100	-3%	-$15K	0.05%	229
2024 Q1	$403K	Hold	2,974	–	–	0.04%	247
2023 Q4	$401K	Hold	2,974	–	–	0.04%	237
2023 Q3	$403K	Hold	2,974	–	–	0.05%	222
2023 Q2	$426K	Hold	2,974	–	–	0.05%	234
2023 Q1	$413K	Hold	2,974	–	–	0.05%	229
2022 Q4	$403K	Buy	2,974 +100	+3%	+$12.5K	0.05%	223
2022 Q3	$315K	Buy	+2,874	New	+$365K	0.04%	240
2022 Q2	–	Sell	-2,624	Closed	-$348K	–	237
2022 Q1	$348K	Hold	2,624	–	–	0.04%	245
2021 Q4	$306K	Hold	2,624	–	–	0.04%	259
2021 Q3	$315K	Buy	+2,624	New	+$305K	0.04%	243

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

XML Financial's AZN Position: Q2 2026 in Review

XML Financial reduced its AstraZeneca (AZN) stake by 5.8% in Q2 2026, selling an estimated $28.2K and leaving 2,449 shares worth $464K. The position accounts for 0.03% of the portfolio, ranked #298.

XML Financial first reported a position in AZN in Q3 2021 and has held it in 19 quarters since. The position peaked at $513K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

XML Financial held 2,449 shares of AstraZeneca worth $464K as of Q2 2026.
XML Financial sold 150 AstraZeneca shares in Q2 2026, an estimated $28.2K.
AstraZeneca made up 0.03% of XML Financial's portfolio in Q2 2026, its #298 holding.
XML Financial first reported a position in AstraZeneca in Q3 2021 and has held it in 19 quarters since.
XML Financial's AstraZeneca position peaked at $513K in Q1 2026.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.